Skip to content
Search

Latest Stories

RPS launches revised 'Professional Standards for Hospital Pharmacy'

The Royal Pharmaceutical Society (RPS) has launched a new revised RPS Professional Standards for Hospital Pharmacy Services at its annual conference held on Friday (11 November).

RPS developed the standards through an extensive consultation with the profession, multidisciplinary teams and patients. They are relevant for providers of pharmacy services in acute, mental health, private, community service, prison, hospice and ambulance settings.


The revised Standards contain two brand new descriptors – research, audit and quality improvement, and inclusion and wellbeing. Updates have been made to the supporting statements to ensure they reflect current practice and are fit for the future. A new assessment tool has been developed to support organisations either self-assess or peer-assess against the Standards.

“For the first time the Standards apply UK wide, having gained support from Pharmacy Forum NI, alongside endorsement from The Association of Pharmacy Technicians UK and other professional groups,” RPS said.

Interim Chair of the RPS Hospital Expert Advisory Group Roger Fernandes said: “This refresh of the RPS Hospital Standards was driven by contributions from colleagues, patients and partner organisations, for which we are very grateful.

“The Standards create consistent quality of patient care across healthcare and provide Chief Pharmacists and Directors of Pharmacy with a set of guidelines against which they can be held accountable. These will be essential in enabling leaders meet the expectations of the General Pharmaceutical Council who will be directly defining their future roles after legislative change comes into force on 01 December this year.”

Claire Steele, President of APTUK said: “We encourage pharmacy technicians to support the application of the standards in their practice, actively strive for continuous improvement in service delivery and help others within the pharmacy team to do so too.”

RPS President Professor Claire Anderson said: “I’m delighted to see the update of this seminal publication which supports pharmacists working across healthcare settings and organisations to lead on implementing continual improvements in patient care.”

RPS has supporting resources highlighting the importance of quality and providing any useful background information on the pharmacy services to help organisations implement the standards in practice. This includes a guide for Chief Pharmacists or equivalents working in Great Britain.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less